ProMetic Life Sciences Inc. - Product Pipeline Review - 2016

  • ID: 3832334
  • Company Profile
  • 42 pages
  • Global Markets Direct
1 of 4
ProMetic Life Sciences Inc. - Product Pipeline Review - 2016

Summary

‘ProMetic Life Sciences Inc. - Product Pipeline Review - 2016’, provides an overview of the ProMetic Life Sciences Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by ProMetic Life Sciences Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of ProMetic Life Sciences Inc.
- The report provides overview of ProMetic Life Sciences Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses ProMetic Life Sciences Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features ProMetic Life Sciences Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate ProMetic Life Sciences Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for ProMetic Life Sciences Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding ProMetic Life Sciences Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

ProMetic Life Sciences Inc. Snapshot

ProMetic Life Sciences Inc. Overview

Key Information

Key Facts

ProMetic Life Sciences Inc. - Research and Development Overview

Key Therapeutic Areas

ProMetic Life Sciences Inc. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

ProMetic Life Sciences Inc. - Pipeline Products Glance

ProMetic Life Sciences Inc. - Late Stage Pipeline Products

Phase III Products/Combination Treatment Modalities

ProMetic Life Sciences Inc. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

ProMetic Life Sciences Inc. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

ProMetic Life Sciences Inc. - Drug Profiles

immune globulin (human)

Product Description

Mechanism of Action

R&D Progress

plasminogen (human)

Product Description

Mechanism of Action

R&D Progress

PBI-4050

Product Description

Mechanism of Action

R&D Progress

alpha-1 proteinase inhibitor (human)

Product Description

Mechanism of Action

R&D Progress

C1 esterase inhibitor (human)

Product Description

Mechanism of Action

R&D Progress

PBI-4419

Product Description

Mechanism of Action

R&D Progress

PBI-4425

Product Description

Mechanism of Action

R&D Progress

PBI-4547

Product Description

Mechanism of Action

R&D Progress

plasminogen (recombinant)

Product Description

Mechanism of Action

R&D Progress

ProMetic Life Sciences Inc. - Pipeline Analysis

ProMetic Life Sciences Inc. - Pipeline Products by Target

ProMetic Life Sciences Inc. - Pipeline Products by Route of Administration

ProMetic Life Sciences Inc. - Pipeline Products by Molecule Type

ProMetic Life Sciences Inc. - Pipeline Products by Mechanism of Action

ProMetic Life Sciences Inc. - Recent Pipeline Updates

ProMetic Life Sciences Inc. - Dormant Projects

ProMetic Life Sciences Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer 42List of Tables

ProMetic Life Sciences Inc., Key Information

ProMetic Life Sciences Inc., Key Facts

ProMetic Life Sciences Inc. - Pipeline by Indication, 2016

ProMetic Life Sciences Inc. - Pipeline by Stage of Development, 2016

ProMetic Life Sciences Inc. - Monotherapy Products in Pipeline, 2016

ProMetic Life Sciences Inc. - Partnered Products in Pipeline, 2016

ProMetic Life Sciences Inc. - Partnered Products/ Combination Treatment Modalities, 2016

ProMetic Life Sciences Inc. - Phase III, 2016

ProMetic Life Sciences Inc. - Phase II, 2016

ProMetic Life Sciences Inc. - Phase I, 2016

ProMetic Life Sciences Inc. - Preclinical, 2016

ProMetic Life Sciences Inc. - Pipeline by Target, 2016

ProMetic Life Sciences Inc. - Pipeline by Route of Administration, 2016

ProMetic Life Sciences Inc. - Pipeline by Molecule Type, 2016

ProMetic Life Sciences Inc. - Pipeline Products by Mechanism of Action, 2016

ProMetic Life Sciences Inc. - Recent Pipeline Updates, 2016

ProMetic Life Sciences Inc. - Dormant Developmental Projects,2016

ProMetic Life Sciences Inc., Other Locations

ProMetic Life Sciences Inc., Subsidiaries 40List of Figures

ProMetic Life Sciences Inc. - Pipeline by Top 10 Indication, 2016

ProMetic Life Sciences Inc. - Pipeline by Stage of Development, 2016

ProMetic Life Sciences Inc. - Monotherapy Products in Pipeline, 2016

ProMetic Life Sciences Inc. - Pipeline by Target, 2016

ProMetic Life Sciences Inc. - Pipeline by Route of Administration, 2016

ProMetic Life Sciences Inc. - Pipeline by Molecule Type, 2016

ProMetic Life Sciences Inc. - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll